Clinical Trial Update: Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]

View source ↗

Summary

Phase 3 trial update for cefepime-tazobactam in complicated urinary tract infection and acute pyelonephritis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• cefepime-tazobactam (cefepime-tazobactam)

Snippet

Sponsor: Wockhardt | Conditions: Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | Status: UNKNOWN